Upload Avatar (500 x 500)
Xianjin Du
Medical School
Wuhan University
Hubei
Language: English, Chinese
Critical Care
Intensive Care
Sepsis
Clinical Research
Emergency Medicine
Inflammation
Organ Protection
Medical Education
Molecular Biology
Biomedical Research
Areas of Focus
- Critical Care Medicine
- Sepsis Research
Work Experience
- 2010.07-2010.12 Physician at Renmin Hospital, Wuhan University
- 2011.01-2016.11 Attending Physician at Renmin Hospital, Wuhan University
- 2014.10-2015.10 Visiting Scholar at SUNY Upstate Medical University; University of Maryland School of Medicine Shock Trauma Center
- 2016.12-2020.11 Associate Chief Physician at Renmin Hospital, Wuhan University
- 2018.10-2020.08 Vice Director of Emergency Department at Renmin Hospital, Wuhan University
- 2020.12-present Chief Physician at Renmin Hospital, Wuhan University
- 2020.08-present Vice Director of Department of Critical Care Medicine I at Renmin Hospital, Wuhan University
Academic Background & Achievements
- 2000.09-2005.06 Bachelor of Clinical Medicine: Wuhan University
- 2005.09-2010.06 PhD in Surgery: Wuhan University
- Visiting Scholar at State University of New York
- Presided over 7 research grants including National Natural Science Foundation of China
Publications
- Artificial Intelligence for Clinical Decision Support in Sepsis, Wu M, Du X, Gu R, Wei J, 2021
- miR-182-5p contributes to intestinal injury in a murine model of Staphylococcus aureus pneumonia-induced sepsis via targeting surfactant protein D, Du X, Wei J, Tian D, Yan C, Hu P, Wu X, Yang W, 2020
- Application of CRISPR/Cas9 technology in sepsis research, Wu M, Hu N, Du X, Wei J, 2020
- MEG3 Alleviated LPS-Induced Intestinal Injury in Sepsis by Modulating miR-129-5p and Surfactant Protein D, Du X, Tian D, Wei J, et al., 2020
- MicroRNA-21 Contributes to Acute Liver Injury in LPS-Induced Sepsis Mice by Inhibiting PPARα Expression, Du X, Wu M, Tian D, Zhou J, Wang L, Zhan L, 2020
- NEAT1 promotes myocardial ischemia-reperfusion injury via activating the MAPK signaling pathway, Du X, Wei J, Tian D, Yan C, Hu P, Wu X, Yang W, Hu X, 2019
- MiR-181a inhibits vascular inflammation induced by ox-LDL via targeting TLR4 in human macrophages, Du X, Lu J, Sha Y, 2018
- Surfactant Proteins SP-A and SP-D Ameliorate Pneumonia Severity and Intestinal Injury in a Murine Model of Staphylococcus Aureus Pneumonia, Du X, Meng Q, Sharif A, Abdel-Razek OA, Zhang L, Wang G, Cooney RN, 2016
- Anti-inflammatory effect of exendin-4 postconditioning during myocardial ischemia and reperfusion, Du X, Hu X, Wei J, 2014
- Postconditioning with rosuvastatin reduces myocardial ischemia-reperfusion injury by inhibiting high mobility group box 1 protein expression, Du X, Hu X, Wei J, 2014
Awards
- 2016.12 Second Prize of Science and Technology Progress, Hubei Province (Rank 4)
- 2015.06 New Investigators Travel Award, American Shock Society
- 2017.12 Second Prize for Excellent Papers in Medical Education and Management, Chinese Medical Association (Rank 1)
